Article
Biology and Treatment of Hairy Cell Leukemia.
Current treatment options in oncology - 30 Apr 2020
Paillassa Jérôme, Troussard Xavier
Abstract excerpt
OPINION STATEMENT: Despite its rarity, hairy cell leukemia (HCL) remains a fascinating disease and the physiopathology is becoming more and more understood. The accurate diagnosis of HCL relies on the recognition of hairy cells by morphology and flow cytometry (FCM) in the blood and/or bone marrow (BM). The BRAF V600E mutation, an HCL-defining mutation, represents a novel diagnostic parameter and a potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
